Related Experiment Video
Updated: Jul 19, 2025

09:02
Validation of a Mouse Model to Disrupt LINC Complexes in a Cell-specific Manner
Published on: December 10, 2015
7.4K
A Knock-In Mouse Model of Cryopyrin-Associated Periodic Syndromes
Arinna Bertoni1, Ignazia Prigione2, Sabrina Chiesa2
1UOC Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy. arinnabertoni@gaslini.org.
Methods in Molecular Biology (Clifton, N.J.)
|August 14, 2023
Summary
Autoinflammatory diseases like CAPS involve innate immune system cytokines. A new mouse model with the NLRP3 N475K mutation aids in studying CINCA, a severe CAPS form.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Autoinflammatory diseases are characterized by recurrent fever and inflammation mediated by innate immune system cytokines, notably IL-1β.
- Cryopyrin-associated periodic syndromes (CAPS), caused by NLRP3 gene mutations, are a primary example of these disorders, often presenting in early childhood.
- The genetic basis of CAPS necessitates the development of animal models for comprehensive study due to challenges with human pediatric samples.
Approach:
- This work details the creation and characterization of a knock-in mouse model.
- The mouse model incorporates a specific mutation (N475K) in the NLRP3 gene.
- This mutation is known to be associated with CINCA (Cold Autoinflammatory Syndrome), the most severe form of CAPS.
Key Points:
- The generated mouse model accurately reflects key aspects of CINCA pathophysiology.
- This model facilitates research into the mechanisms underlying autoinflammatory conditions.
- It serves as a valuable tool for evaluating potential therapeutic strategies for CAPS.
Conclusions:
- The NLRP3 N475K knock-in mouse is a significant advancement for studying CINCA and related autoinflammatory diseases.
- This model offers new avenues for understanding innate immunity and IL-1β-driven inflammation.
- Further research using this model is expected to accelerate the development of targeted therapies for CAPS patients.
Keywords:
Autoinflammatory diseasesBone marrow precursorsCAPSIL-1β secretionKnock-in mouse for NLRP3 gene
